Daniel Acker/Bloomberg via Getty Images

Hazards in the lab

Science | Risky viral research gets a government green light
by Julie Borg
Posted 3/14/19, 03:54 pm

The United States government has quietly resumed funding for certain high-risk viral experiments that regulators had blocked for four years, according to a February report by Science magazine.

Read more

Jessica Hill/AP

Anatomy of an epidemic

Drug Abuse | Diagnosing the causes of the opioid crisis 
by Charles Horton
Posted 2/28/19, 01:46 pm

Massachusetts officials are suing Purdue Pharma, maker of OxyContin, alleging that its sales tactics fueled a surge in opioid addiction. Massachusetts is also suing the Sackler family, which owns and runs Purdue Pharma. The lawsuit underscores the controversy over the pills: Did the increase in opioid prescriptions reflect doctors finally addressing untreated pain or becoming tools for sales at any cost?

Read more


Treatment in sight

Science | Non-embryonic stem cells could treat age-related blindness
by Julie Borg
Posted 2/14/19, 03:15 pm

Nearly 11 million Americans suffer from age-related macular degeneration (AMD), the leading cause of vision loss in people 65 and older. Currently, no cure exists.

Read more